Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04337970
Title Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

renal cell carcinoma


Axitinib + Talazoparib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.